Use of (alternative) coreceptors for HIV entry

Current Opinion in HIV and AIDS

Volumn 7, Issue 5, 2012, Pages 440-449

  Pollakis, Georgios ^a   Paxton, William A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

C type lectins; CCR5; CXCR4; HIV 1 coreceptors; transmission and disease progression

Indexed keywords

APELIN RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR8; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR CXCR7; GLYCOPROTEIN GP 120; LECTIN;

CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE COURSE; GENETIC POLYMORPHISM; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LANGERHANS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; REVIEW; VIRUS ENTRY; VIRUS REPLICATION; VIRUS TRANSMISSION;

HIV INFECTIONS; HIV-1; HUMANS; LECTINS; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV; VIRAL TROPISM; VIRUS INTERNALIZATION;

EID: 84865652575     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328356e9f3     Document Type: Review

References (93)

1. Dalgleish AG, Beverley PC, Clapham PR, et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312:763-767.
2. Paxton WA, Dragic T, Koup RA, Moore JP. The beta-chemokines, HIV type 1 receptors, and exposed uninfected persons. AIDS Res Hum Retroviruses 1996; 12:1203-1207.
3. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999; 17:657-700.
4. Centlivre M, Legrand N, Steingrover R, et al. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J Leukoc Biol 2011; 89:785-795
5. Boy SC, van Heerden MB, Wolfaardt M, et al. An investigation of the role of oral epithelial cells and Langerhans cells as possible HIV viral reservoirs. J Oral Pathol Med 2009; 38:114-119.
6. Almodovar S, Colon M, Maldonado I, et al. HIV-1 infection of monocytes is directly related to the success of HAART. Virology 2007; 369:35-46.
7. Va'zquez M, Maldonado IM, Almodóvar S, et al. Human blood dendritic cells are infected separately from monocytes in HIV type 1 patients. AIDS Res Hum Retroviruses 2010; 26:471-479.
8. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009; 458:1034-1038.
9. Steinsvoll S, Helgeland K, Schenck K. Mast cells - a role in periodontal diseases? J Clin Periodontol 2004; 31:413-419.
10. Sucupira MC, Sanabani S, Cortes RM, et al. Faster HIV-1 disease progression among Brazilian individuals recently infected with CXCR4-utilizing strains. PLoS One 2012; 7:e30292
11. Chalmet K, Dauwe K, Foquet L, et al. Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: Correlates and evidence for transmission. J Infect Dis 2012; 205:174-184
12. Hedskog C, Mild M, Albert J. Transmission of the X4 phenotype of HIV-1: Is there evidence against the 'random transmission' hypothesis? J Infect Dis 2012; 205:163-165.
13. Rieder P, Joos B, Scherrer AU, et al. Characterization of human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection. Clin Infect Dis 2011; 53:1271-1279
14. Cutler CW, Jotwani R. Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: Tableau of resistance or susceptibilityto HIV infection? Adv ent Res 2006; 19:49-51.
15. Prodger JL, Gray R, Kigozi G, et al. Foreskin T-cell subsets differ substantially from blood with respect to HIV co-receptor expression, inflammatory profile, and memory status. Mucosal Immunol 2012; 5:121-128
16. McKinnon LR, Nyanga B, Chege D, et al. Characterization of a human cervical CD4 T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 2011; 187:6032-6042
17. Kader M, Wang X, Piatak M, et al. Alpha4 beta7(hi)CD4 memory T cellsharbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol 2009; 2:439-449.
18. Meditz AL, Moreau KL, MaWhinney S, et al. CCR5 expression is elevated on endocervical CD4 T cells in healthy postmenopausal women. J Acquir Immune Defic Syndr 2012; 59:221-228.
19. Cabrera-Mun̈oz E, Fuentes-Romero LL, Zamora-Chávez J, et al. Effects of progesterone on the content of CCR5 and CXCR4 coreceptors in PBMCs of seropositive and exposed but uninfected Mexican women to HIV-1. J Steroid Biochem Mol Biol 2012; 132:66-72.
20. Cavarelli M, Karlsson I, Ripamonti C, et al. Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children. AIDS 2010; 24:2527-2533.
21. Ho Tsong Fang R, Colantonio AD, Uittenbogaart CH. The role of the thymus in HIV infection: A 10 year perspective. AIDS 2008; 22:171-184.
22. Doms RW, Trono D. The plasma membrane as a combat zone in the HIV battlefield. Genes Dev 2000; 14:2677-2688.
23. Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses2004; 20:111-126.
24. Shimizu N, Soda Y, Kanbe K, et al. A putative G protein coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. J Virol 2000; 74:619-626.
25. Combadiere C, Salzwedel K, Smith ED, et al. Identification of CX3CR1. A Chemotactic Receptor For The Human CX3C Chemokine Fractalkine And A Fusion Coreceptor For HIV-1. J Biol Chem 1998; 273:23799-23804.
26. Samson M, Edinger AL, Stordeur P, et al. ChemR23, a putative chemoattractant receptor, is expressed in monocytes derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol 1998; 28:1689-1700.
27. Shimizu N, Tanaka A, Mori T, et al. A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus. Retrovirology 2008; 5:52.
28. Simmons G, Reeves JD, Hibbitts S, et al. Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev 2000; 177:112-126.
29. Gosselin A, Monteiro P, Chomont N, et al. Peripheral blood CCR4CCR6 and CXCR3CCR6CD4 T cells are highly permissive to HIV-1 infection. J Immunol 2010; 18:1604-1616.
30. Monteiro P, Gosselin A, Wacleche VS, et al. Memory CCR6CD4 T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin b7. J Immunol 2011; 186:4618-4630
31. Wang C, Kang SG, Lee J, et al. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2009; 2:173-183.
32. Reboldi A, Coisne C, Baumjohann D, et al. C-C chemokine receptor 6- regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009; 10:514-523.
33. Calado M, Matoso P, Santos-Costa Q, Espirito-Santo M, et al. Coreceptor usage by HIV-1 and HIV-2 primary isolates: The relevance of CCR8 chemokine receptor as an alternative coreceptor. Virology 2010; 408:174-182.
34. Jinno A, Shimizu N, Soda Y, et al. Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection. Biochem Biophys Res Commun 1998; 243:497- 502.
35. Shimizu N, Tanaka A, Oue A, et al. Broad usage spectrum of G proteincoupled receptors as coreceptors by primary isolates of HIV. AIDS 2009; 23:761-769.
36. Shimizu N, Tanaka A, Jinno-Oue A, et al. Identification of the conformational requirement for the specificities of coreceptors for human and simian immunodeficiency viruses. AIDS Res Hum Retroviruses 2010; 26:321-328.
37. Riddick NE, Hermann EA, Loftin LM, et al. A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog 2010; 6:e1001064.
38. Tripathi V, Verma R, Dinda A, et al. Differential expression of RDC1/CXCR7 inthe human placenta. J Clin Immunol 2009; 29:379-386.
39. Jiang C, Parrish NF, Wilen CB, et al. Primary infection by a human immunodeficiency virus with atypical coreceptor tropism. J Virol 2011; 85:10669- 10681.
40. Passam AM, Sourvinos G, Krambovitis E, et al. Polymorphisms of Cx(3)CR1 and CXCR6 receptors in relation to HAART therapy of HIV type 1 patients. AIDS Res Hum Retroviruses 2007; 23:1026-1032.
41. Hirbod T, Bailey RC, Agot K, et al. Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. Am JPathol 2010; 176:2798-2805.
42. Hirbod T, KaldensjóT, Broliden K. In situ distribution of HIV-binding CCR5 and C-type lectin receptors in the human endocervical mucosa. PLoS One 2011; 6:e25551.
43. Hirbod T, KaldensjóT, Lopalco L, et al. Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection. J Acquir Immune Defic Syndr 2009; 51:239-247.
44. Shen R, Smythies LE, Clements RH, et al. Dendritic cells transmit HIV-1 through human small intestinal mucosa. J Leukoc Biol 2010; 87:663- 670.
45. Da Silva RC, Segat L, Crovella S. Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. Hum Immunol 2011; 72:305-311.
46. Wu L, KewalRamani VN. Dendritic-cell interactions with HIV: Infection and viral dissemination. Nat Rev Immunol 2006; 6:859-868.
47. Lekkerkerker AN, van Kooyk Y, Geijtenbeek TB. Viral piracy: HIV-1 targets dendritic cells for transmission. Curr HIV Res 2006; 4:169-176.
48. Van der Vlist M, van der Aar AM, Gringhuis SI, et al. Innate signaling in HIV-1 infection of dendritic cells. Curr Opin HIV AIDS 2011; 6:348-352.
49. Gringhuis SI, van der Vlist M, van den Berg LM, et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells.Nat Immunol 2010; 11:419-426.
50. Tsegaye TS, Póhlmann S. The multiple facets of HIV attachment to dendritic cell lectins. Cell Microbiol 2010; 12:1553-1561.
51. Hijazi K, Wang Y, Scala C, et al. DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4. PLoS One 2011; 6:e28307.
52. Van Montfort T, Eggink D, Boot M, et al. HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation. J Immunol 2011; 187:4676-4685.
53. Raska M, Takahashi K, Czernekova L, et al. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.J Biol Chem 2010; 285:20860-20869.
54. Van Montfort T, Nabatov AA, Geijtenbeek TB, et al. Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4 T lymphocytes. J Immunol 2007; 178:3177-3185.
55. Van Montfort T, Thomas AA, Pollakis G, Paxton WA. Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virustype 1 variants to CD4 T lymphocytes in trans. J Virol 2008; 82:7886-7896.
56. Tjomsland V, Ellega° rd R, Che K, et al. Complement opsonization of HIV-1 enhances the uptake by dendritic cells and involves the endocytic lectin andintegrin receptor families. PLoS One 2011; 6:e23542.
57. Vázquez-Guillén JM, García-Jacobo PJ, Zapata-Benavides P, et al. Expression of DC-SIGN in peripheral blood dendritic cells of patients with typical, slow, and rapid progression to AIDS. Arch Med Res 2009; 40:132-135.
58. Selvaraj P, Alagarasu K, Swaminathan S, et al. CD209 gene polymorphisms in south Indian HIV and HIV-TB patients. Infect Genet Evol 2009; 9:256- 262.
59. Martin MP, Lederman MM, Hutcheson HB, et al. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 2004;78:14053-14056.
60. Zhang J, Zhang X, Fu J, et al. Protective role of DC-SIGN (CD209) neckregion alleles with <5 repeat units in HIV-1 transmission. J Infect Dis 2008; 198:68-71.
61. Rathore A, Chatterjee A, Sivarama P, et al. Role of homozygous DC-SIGNR 5/ 5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indianindividuals. J Clin Immunol 2008; 28:50-57.
62. Wang H, Wang C, Feng T, et al. DC-SIGNR polymorphisms and its association with HIV-1 infection. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2008; 25:542-545.
63. Wichukchinda N, Kitamura Y, Rojanawiwat A, et al. The polymorphisms in DCSIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses 2007; 23:686-692.
64. Zhu D, Kawana-Tachikawa A, Iwamoto A, Kitamura Y. Influence of polymorphism in dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related (DC-SIGNR) gene on HIV-1 trans-infection. Biochem Biophys Res Commun 2010; 393:598-602.
65. Naarding MA, Dirac AM, Ludwig IS, et al. Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4 T cells. Antimicrob Agents Chemother 2006; 50:3367- 3374.
66. Saeland E, de Jong MA, Nabatov AA, et al. MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol Immunol 2009; 46:2309-2316.
67. Sabatte J, Faigle W, Ceballos A, et al. Semen clusterin is a novel DC-SIGN ligand. J Immunol 2011; 187:5299-5309.
68. Stax MJ, Naarding M, Tanck-Michael WT, et al. Binding of human milk to pathogen receptor DC-SIGN varies with bile salt-stimulated lipase (BSSL) gene polymorphism. PLoS One 2011; 6:e17316.
69. Stax MJ, Kootstra NA, van 't Wout AB, et al. HIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism. PLoS One 2012; 7:e32534
70. Panicot-Dubois L, Thomas GM, Furie BC, et al. Bile salt-dependent lipaseinteracts with platelet CXCR4 and modulates thrombus formation in mice and humans. J Clin Invest 2007; 117:3708-3719.
71. De Witte L, Nabatov A, Pion M, et al. Langerin is a natural barrier to HIV-1transmission by Langerhans cells. Nat Med 2007; 13:367-371.
72. Kawamura T, Gulden FO, Sugaya M, et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc Natl Acad Sci USA 2003; 100:8401-8406.
73. Reece JC, Handley AJ, Anstee EJ, et al. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J Exp Med 1998; 187:1623- 1631.
74. Ballweber L, Robinson B, Kreger A, et al. Vaginal Langerhans cells nonproductively transporting HIV-1 mediate infection of T cells. J Virol 2011; 85:13443- 13447.
75. Holla A, Skerra A. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin. Protein Eng Des Sel 2011; 24:659-669
76. Andreini M, Doknic D, Sutkeviciute I, et al. Second generation of fucosebased DC-SIGN ligands: Affinity improvement and specificity versus Langerin.Org Biomol Chem 2011; 9:5778-5786.
77. Froelich S, Tai A, Kennedy K, et al. Pseudotyping lentiviral vectors with auravirus envelope glycoproteins for DC-SIGN-mediated transduction of dendriticcells. Hum Gene Ther 2011; 22:1281-1291.
78. Gramberg T, Soilleux E, Fisch T, et al. Interactions of LSECtin and DC-SIGN/ DC-SIGNR with viral ligands: Differential pH dependence, internalization andvirion binding. Virology 2008; 373:189-201.
79. Lambert AA, Gilbert C, Richard M, et al. The C-type lectin surface receptorDCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributesto trans- and cis-infection pathways. Blood 2008; 112:1299-1307.
80. Lambert AA, BarabéF, Gilbert C, Tremblay MJ. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 2011; 117:6589-6599
81. Lambert AA, Imbeault M, Gilbert C, Tremblay MJ. HIV-1 induces DCIR expression in CD4 T cells. PLoS Pathog 2010; 6:e1001188.
82. Graham LM, Brown GD. The Dectin-2 family of C-type lectins in immunity and homeostasis. Cytokine 2009; 48:148-155.
83. Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ, et al. Targeting DCIR onhuman plasmacytoid dendritic cells results in antigen presentation and inhibitsIFN-alpha production. Blood 2008; 111:4245-4253.
84. Le Cabec V, Emorine LJ, Toesca I, et al. The human macrophage mannosereceptor is not a professional phagocytic receptor. J Leukoc Biol 2005;77:934-943.
85. Trujillo JR, Rogers R, Molina RM, et al. Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor. ProcNatl Acad Sci USA 2007; 104:5097-5102.
86. Cardona-Maya W, Velilla PA, Montoya CJ, et al. In vitro human immunodeficiency virus and sperm cell interaction mediated by the mannose receptor. J Reprod Immunol 2011; 92:1-7.
87. Marttila-Ichihara F, Turja R, Miiluniemi M, et al. Macrophage mannose receptor on lymphatics controls cell trafficking. Blood 2008; 112:64-72.
88. Fanibunda SE, Modi DN, Gokral JS, Bandivdekar AH. HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases. PLoS One 2011; 6:e28014.
89. Chatterjee A, Rathore A, Yamamoto N, Dhole TN. Mannose-binding lectin (54) exon-1 gene polymorphism influence human immunodeficiency virus-1 susceptibility in North Indians. Tissue Antigens 2011; 77:18-22.
90. Vallinoto AC, Freitas FB, Guirelli I, et al. Characterization of mannose-binding lectin plasma levels and genetic polymorphisms in HIV-1-infected individuals. Rev Soc Bras Med Trop 2011; 44:1-3.
91. Singh KK, Nathamu S, Adame A, et al. Expression of mannose binding lectin in HIV-1-infected brain: Implications for HIV-related neuronal damage and neuroAIDS. Neurobehav HIV Med 2011; 3:41-52.
92. Chaipan C, Soilleux EJ, Simpson P, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol 2006; 80:8951-8960.
93. Chaipan C, Steffen I, Tsegaye TS, et al. Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2. Retrovirology 2010; 7:47.